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Background
Methods
Study Design:
• Cross-sectional study of 632 consenting injection drug users in Cairo and Alexandria seeking
harm reduction services.
Hypothesis:
• PWID who share needles are at an increased odds of HIV and HCV seropositivity compared to
those who do not share needles.
• PWID who share needles have both high and low-risk sexual partners.
Analysis:
• Examined the links between needle-sharing PWID’s sexual practices and the general
population.
• Multiple logistic regression evaluated the associations between high-risk injection drug use
and sexual practices and HIV/HCV status using SAS 9.4.
Partners:
• Conducted in partnership with Freedom Drugs and HIV Programme, Egypt.
• Funded by NIH/National Institute of Allergy and Infectious Diseases (Project Number
5R21DA033888-02).
Results
Conclusions
Among PWID in Egypt:
• More than half of PWID who have a high-risk sex partner, share needles with >10 people, and frequently share needles
also have a low-risk sex partner.
• The general population is at risk of HIV/HCV primarily through sexual contact.
• Those who shared needles with >10 people had higher odds of testing positive for HIV.
• Those more years of injection drug use had higher odds of testing positive for HCV.
• In agreement with the literature, higher education is associated with lower odds of HIV/HCV, and older age is associated
with higher odds of HIV/HCV.
Significance:
• In Egypt repressive policies that include low education and lack of harm reduction programs may place the general
population at risk for HIV/HCV.
• In Russia, repressive policies toward PWID allowed HIV to spread to the general population and the country has seen a
49% increase in HIV prevalence 2005-2015. Egypt could see a similar trajectory in HIV prevalence.
• Common-sense harm reduction programs like clean needle exchanges and decriminalization of injection drug use are
needed to control the spread of HIV and HCV in Egypt.
Table 1: Summary of demographic indicators by HIV/HCV status and unadjusted odds ratios (UOR).
HIV (n=604) HCV (n=624) Study vs. General Pop.
Positive (row %) UOR Positive (row %) UOR Study Egypt
Male 61 (10.97) ref 359 (62.54) ref 92.09% a51.22%
Female 3 (6.25) 0.541 25 (50.00) *0.599 7.91% a48.78%
18-25 years of age 8 (5.48) ref 60 (39.47) ref 24.29% b16.00%
26-35 34 (10.93) *2.117 203 (63.44) **2.660 51.43% b16.30%
36+ 22 (15.17) **3.085 120 (79.47) **5.935 24.29% b25.90%
No Education 6 (28.57) ref 17 (73.91) ref 3.64% c19.50%
Less than University 43 (10.94) **0.307 253 (62.16) 0.580 64.87% c67.90%
University or Higher 15 (7.89) **0.214 114 (58.76) 0.503 31.49% c12.70%
Relationship status: Single 30 (12.77) ref 125 (51.23) ref 39.08% c25.90%
In a Relationship 3 (5.66) 0.410 30 (54.55) 1.142 8.70% c0.00%
Married 21 (10.10) 0.767 149 (70.62) **2.288 33.86% c69.70%
Divorced/Separated/Widowed 10 (9.26) 0.697 80 (70.18) **2.240 18.35% c4.50%
Unemployed 9 (8.57) ref 65 (57.02) ref 18.60% a9.90%
Employed 54 (10.89) 1.303 317 (62.52) 1.258 81.40% a90.10%
p-val <0.1*, p-val <0.05**; aEgypt Development Indicators, 2013; bUS Census International Data Base, 2015; 
cDemographic and Health Survey, 2014
Figure 1: Venn-diagrams A-C summarize the overlap between behavioral indicators known to contribute to the spread of HIV in 
the general population, where high-risk sex partners include men who have sex with men (MSM), sex-workers, and drug 
dealers, and low-risk sex partners are those of steady relationships or spouses.
55% of those with any high-risk sex partners 
also have at least one low-risk sex partner.
55% of those who share needles with >10 
people also have at least one low-risk sex 
partner.
68% of those who share needles half-the-
time or every-time also have at least one 
low-risk sex partner.
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Table 3: Marginal difference in probability of testing HIV+ for 
change in the number of people PWID shared needle with*, 
keeping all other model indicators at their most frequent value in 
the study population.
Age Sex Education
Years of 
Injection 
Drug Use
Number 
Shared 
Needle 
With*
No. Sex 
Partners 
Last 6 mo.
Marginal 
Difference
26-35 M <University 2-9
1-10
1 0.15958
>10
Compared to PWID who share needles with 1-10 people:
• PWID who share needles with >10 people have 16% higher 
probability of testing HIV positive.
Table 4: Marginal difference in probability of testing HCV+ for 
change in duration of injection drug use*, keeping all other model 
indicators at their most frequent value in the study population.
Age Sex Education
Years of 
Injection 
Drug Use*
Number Shared 
Needle With
Marginal 
Difference
26-35 M <University
0-1
1-10 0.23873
2-9
26-35 M <University
0-1
1-10 0.32275
10-19
26-35 M <University
0-1
1-10 0.4627
20+
Compared to PWID who have been using injection drugs for 0-1 year:
• PWID who have been using for 2-9 years have 24% higher 
probability of testing HCV positive.
• PWID who have been using for 10-19 years have 32% higher 
probability of testing HCV positive.
• PWID who have been using for 20+ years have 46% higher 
probability of testing HCV positive.
• Egypt has the greatest HCV prevalence worldwide at 15%.
• The concentrated HIV epidemic in male people who inject
drugs (PWID) is at 6.8%.
• Injection drug use is criminalized in Egypt, and there are
limited harm reduction programs.
• Previous studies in Egypt found 53% of male PWID used
needles that had been used by others and 89% had a
regular female sex partner.1
• This is the first study examining the sexual links between
PWID and the general population in Egypt.
1Soliman, et al. (2010). HIV prevalence and risk behaviors of male injection drug users in Cairo, 
Egypt. AIDS, 24, S33-S38
Table 2: Multiple logistic regression models of HIV and HCV.
HIV Model HCV Model
OR (95% CI) OR (95% CI)
Male ref ref
Female
1.593 1.337
(0.179-14.164) (0.559-3.200)
18-25 years of age ref ref
26-35
2.925 **2.412
(0.593-14.431) (1.365-4.261)
36+
2.288 **3.011
(0.355-14.762) (1.335-6.788)
No Education ref ref
Less than University
*0.206 *0.22
(0.033-1.298) (0.044-1.095)
University or Higher
*0.158 **0.174
(0.023-1.111) (0.034-0.896)
0-1 years of inj. drug use ref ref
2-9
0.880 **2.666
(0.101-7.673) (1.087-6.540)
10-19
0.707 **3.815
(0.071-7.007) (1.372-10.607)
20+
0.337 **7.912
(0.014-8.166) (1.557-40.197)
Shared Needles with 1-10 People ref ref
>10
**5.112 1.223
(1.925 13.577) (0.622-2.403)
No Sex Partners Last 6 mo. ref
1
0.882
(0.349-2.231)
>1
>999.999
(<0.001->999.9)
p-val <0.1*, p-val <0.05**
